Arthritis Foundation Receives $1 Million Gift from Longtime Partner Alpha Omicron Pi Fraternity
ATLANTA, GA / ACCESSWIRE / July 19, 2023 / The Arthritis Foundation announced it has received its largest gift to-date...
Month: July 2023
VidaTalk’s Talk-to-Translate Feature Will Have a Transformative Impact on Hospitalized Patients With Language Barriers
Achieving the standard of care, no matter the language or disability.ANN ARBOR, MI / ACCESSWIRE / July 19, 2023 /...
Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
New data demonstrates that ART26.12 works by activating multiple receptors implicated in pain signaling and is able to broadly modify...
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”),...
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered LivesMALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc....
Abeona Therapeutics Joins Rare Disease Company Coalition
CLEVELAND, July 19, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has joined the Rare...
Zymeworks To Host Second Quarter 2023 Results Conference Call
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional...
QM Racing Inc., a 100% owned subsidiary of Quad M Solutions, Inc., signs definitive agreement to purchase 100 percent of REV Technologies.
Garland, TX, July 19, 2023 (GLOBE NEWSWIRE) -- QM Racing, Inc. (QM Racing), a subsidiary of Quad M Solutions, Inc., (OTC:...
Carmot Therapeutics Appoints Charles W. Newton to Board of Directors
Biotechnology industry executive and former healthcare investment banker with proven track record of advising management teams on corporate and financial...
Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023
Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023SCOTTSDALE,...
Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
– Conference call and webcast to be held on July 26, 2023, at 8am ET – BOSTON, July 19, 2023...
Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040There are...
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),...
Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer
NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing...
Emergex Reports Promising Data from Completed Swiss Phase I Trial of CoronaTcP™, T Cell-Priming Immune Set-Point Candidate for Betacoronaviruses
First-in-human intradermal administration of CoronaTcP™ was generally well-toleratedEvidence for generation of virus-specific effector and memory CD8+ T cellsData reinforce findings...
Oculis to Present at OIS Retina Innovation Summit
ZUG, Switzerland, and BOSTON, July 19, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company...
Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome
Results of The CAREgiver Burden in BBS (CARE-BBS) study show multifaceted burden of hyperphagiaBOSTON, July 19, 2023 (GLOBE NEWSWIRE) --...
Hydreight Provides Corporate Update Citing Tremendous Growth Along With New Features And Services
VANCOUVER, British Columbia and LAS VEGAS, July 19, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:...
HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)...
MindBio Therapeutics World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder Begins Pre-Screening Participants
Patients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials...